Literature DB >> 28766097

Ranking docking poses by graph matching of protein-ligand interactions: lessons learned from the D3R Grand Challenge 2.

Priscila da Silva Figueiredo Celestino Gomes1,2, Franck Da Silva1, Guillaume Bret1, Didier Rognan3.   

Abstract

A novel docking challenge has been set by the Drug Design Data Resource (D3R) in order to predict the pose and affinity ranking of a set of Farnesoid X receptor (FXR) agonists, prior to the public release of their bound X-ray structures and potencies. In a first phase, 36 agonists were docked to 26 Protein Data Bank (PDB) structures of the FXR receptor, and next rescored using the in-house developed GRIM method. GRIM aligns protein-ligand interaction patterns of docked poses to those of available PDB templates for the target protein, and rescore poses by a graph matching method. In agreement with results obtained during the previous 2015 docking challenge, we clearly show that GRIM rescoring improves the overall quality of top-ranked poses by prioritizing interaction patterns already visited in the PDB. Importantly, this challenge enables us to refine the applicability domain of the method by better defining the conditions of its success. We notably show that rescoring apolar ligands in hydrophobic pockets leads to frequent GRIM failures. In the second phase, 102 FXR agonists were ranked by decreasing affinity according to the Gibbs free energy of the corresponding GRIM-selected poses, computed by the HYDE scoring function. Interestingly, this fast and simple rescoring scheme provided the third most accurate ranking method among 57 contributions. Although the obtained ranking is still unsuitable for hit to lead optimization, the GRIM-HYDE scoring scheme is accurate and fast enough to post-process virtual screening data.

Entities:  

Keywords:  D3R; Docking; Drug discovery data resource; Grand Challenge

Mesh:

Substances:

Year:  2017        PMID: 28766097     DOI: 10.1007/s10822-017-0046-1

Source DB:  PubMed          Journal:  J Comput Aided Mol Des        ISSN: 0920-654X            Impact factor:   3.686


  27 in total

1.  The Protein Data Bank.

Authors:  H M Berman; J Westbrook; Z Feng; G Gilliland; T N Bhat; H Weissig; I N Shindyalov; P E Bourne
Journal:  Nucleic Acids Res       Date:  2000-01-01       Impact factor: 16.971

Review 2.  Molecular recognition and docking algorithms.

Authors:  Natasja Brooijmans; Irwin D Kuntz
Journal:  Annu Rev Biophys Biomol Struct       Date:  2003-01-28

3.  Optimization of a novel class of benzimidazole-based farnesoid X receptor (FXR) agonists to improve physicochemical and ADME properties.

Authors:  Hans G F Richter; G M Benson; K H Bleicher; D Blum; E Chaput; N Clemann; S Feng; C Gardes; U Grether; P Hartman; B Kuhn; R E Martin; J-M Plancher; M G Rudolph; F Schuler; S Taylor
Journal:  Bioorg Med Chem Lett       Date:  2010-12-31       Impact factor: 2.823

4.  Knowledge-Based Strategy to Improve Ligand Pose Prediction Accuracy for Lead Optimization.

Authors:  Cen Gao; Nels Thorsteinson; Ian Watson; Jibo Wang; Michal Vieth
Journal:  J Chem Inf Model       Date:  2015-07-08       Impact factor: 4.956

5.  POSIT: Flexible Shape-Guided Docking For Pose Prediction.

Authors:  Brian P Kelley; Scott P Brown; Gregory L Warren; Steven W Muchmore
Journal:  J Chem Inf Model       Date:  2015-07-24       Impact factor: 4.956

Review 6.  The impact of in silico screening in the discovery of novel and safer drug candidates.

Authors:  Didier Rognan
Journal:  Pharmacol Ther       Date:  2017-02-14       Impact factor: 12.310

7.  Conformationally constrained farnesoid X receptor (FXR) agonists: heteroaryl replacements of the naphthalene.

Authors:  Jonathan Y Bass; Justin A Caravella; Lihong Chen; Katrina L Creech; David N Deaton; Kevin P Madauss; Harry B Marr; Robert B McFadyen; Aaron B Miller; Wendy Y Mills; Frank Navas; Derek J Parks; Terrence L Smalley; Paul K Spearing; Dan Todd; Shawn P Williams; G Bruce Wisely
Journal:  Bioorg Med Chem Lett       Date:  2010-12-23       Impact factor: 2.823

8.  D3R grand challenge 2015: Evaluation of protein-ligand pose and affinity predictions.

Authors:  Symon Gathiaka; Shuai Liu; Michael Chiu; Huanwang Yang; Jeanne A Stuckey; You Na Kang; Jim Delproposto; Ginger Kubish; James B Dunbar; Heather A Carlson; Stephen K Burley; W Patrick Walters; Rommie E Amaro; Victoria A Feher; Michael K Gilson
Journal:  J Comput Aided Mol Des       Date:  2016-09-30       Impact factor: 3.686

9.  Lessons Learned over Four Benchmark Exercises from the Community Structure-Activity Resource.

Authors:  Heather A Carlson
Journal:  J Chem Inf Model       Date:  2016-06-27       Impact factor: 4.956

10.  CSAR benchmark exercise of 2010: combined evaluation across all submitted scoring functions.

Authors:  Richard D Smith; James B Dunbar; Peter Man-Un Ung; Emilio X Esposito; Chao-Yie Yang; Shaomeng Wang; Heather A Carlson
Journal:  J Chem Inf Model       Date:  2011-08-29       Impact factor: 4.956

View more
  4 in total

1.  Sampling and refinement protocols for template-based macrocycle docking: 2018 D3R Grand Challenge 4.

Authors:  Sergei Kotelnikov; Andrey Alekseenko; Cong Liu; Mikhail Ignatov; Dzmitry Padhorny; Emiliano Brini; Mark Lukin; Evangelos Coutsias; Ken A Dill; Dima Kozakov
Journal:  J Comput Aided Mol Des       Date:  2019-12-26       Impact factor: 3.686

2.  D3R grand challenge 4: blind prediction of protein-ligand poses, affinity rankings, and relative binding free energies.

Authors:  Conor D Parks; Zied Gaieb; Michael Chiu; Huanwang Yang; Chenghua Shao; W Patrick Walters; Johanna M Jansen; Georgia McGaughey; Richard A Lewis; Scott D Bembenek; Michael K Ameriks; Tara Mirzadegan; Stephen K Burley; Rommie E Amaro; Michael K Gilson
Journal:  J Comput Aided Mol Des       Date:  2020-01-23       Impact factor: 3.686

3.  Predicting Accurate Lead Structures for Screening Molecular Libraries: A Quantum Crystallographic Approach.

Authors:  Suman Kumar Mandal; Parthapratim Munshi
Journal:  Molecules       Date:  2021-04-29       Impact factor: 4.411

4.  Potential repurposing of four FDA approved compounds with antiplasmodial activity identified through proteome scale computational drug discovery and in vitro assay.

Authors:  Bakary N'tji Diallo; Tarryn Swart; Heinrich C Hoppe; Özlem Tastan Bishop; Kevin Lobb
Journal:  Sci Rep       Date:  2021-01-14       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.